BioNTech (NASDAQ: BNTX) shares are trading lower on Tuesday after Bank Of America downgraded the stock from Buy to Neutral.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19.
BioNTech’s shares were trading down 2% at $121.75 on Tuesday at the time of publication. The stock has a 52-week high of $128.13 and a 52-week low of $20.72.
CollPlant Biotechnologies (NASDAQ: CLGN) shares are trading higher after the company reported third-quarter sales of $4.10 million up from $679,000 year-over-year.
CollPlant Biotechnologies is a regenerative medicine company. It’s focused on developing and commercializing tissue repair products, initially for 3D-bio printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets.
CollPlant Biotechnologies shares were trading up 1.51% at $8.05. The stock has a 52-week high of $14.55 and a 52-week low of $4.77.
Allscripts Healthcare Solutions (NASDAQ: MDRX) shares are trading higher after the company reported a $200 million accelerated buyback.
Allscripts Healthcare Solutions provides information technology and offerings to acute and ambulatory providers as well as hospital services. The company supports electric medical records, private cloud hosting, and other clinical services that support patient engagement and better outcomes.
Allscripts Healthcare Solutions shares were trading up 3.58% at $14.17. The stock has a 52-week high of $14.48 and a 52-week low of $4.56.
Axsome Therapeutics (NASDAQ: AXSM) shares are trading higher after the company announced efficacy and safety results from Phase 3 COMET long-term trial and COMET-AU trial of AXS-05 in major depressive disorder.
Axsome Therapeutics is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options.
Axsome Therapeutics shares were trading up 0.49% at $72.84. The stock has a 52-week high of $109.94 and a 52-week low of $35.44.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.